Abstract
Pain is a side effect of botulinum toxin type-A (BTX-A) injections. The efficiency of the preservative-containing saline solution used as the “dilution solution” for controlling the pain felt during multiple injections in different areas has been investigated by a prospective, randomized, single-blinded, controlled study. A total of 93 patients were divided into three groups for the study. All the patients were given BTX-A. Of these 93 patients, 60 received injections in the upper face, 15 in the neck, and 18 in the axillary regions. The visual analog scale (VAS), a single-dimension pain intensity rating scale, was used to evaluate pain perception. The average VAS values for pain sensation experienced by the groups were 1.2 of 10 points for the upper face area in the experimental group (n = 60) and 4.5 point for the control group. In the neck region (n = 15), the respective scores were 0.6 in the experimental group and 3.9 in the control group. Finally, in the axillary region (n = 18), the respective values were 0.9 and 5.1. The authors conclude that the preservative-containing saline solution significantly decreased pain perception during BTX-A injections (p = 0.000).
Similar content being viewed by others
References
S Laborde Particlevan JS Dover M Moore B Stewart KA Arndt M Alam (2003) ArticleTitleReduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial J Am Acad Dermatol 48 875–877 Occurrence Handle12789177
M Alam JS Dover KA Arndt (2002) ArticleTitlePain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative Arch Dermatol 138 510–514 Occurrence Handle1:CAS:528:DC%2BD38XjtlCjsbo%3D Occurrence Handle11939813
EK Breivik GA Bjornsson E Skovlund (2000) ArticleTitleA comparison of pain rating scales by sampling from clinical trial data Clin J Pain 16 22–28 Occurrence Handle1:STN:280:DC%2BD3c3gtlymuw%3D%3D Occurrence Handle10741815
FS Brandt B Bellman (1998) ArticleTitleCosmetic use of botulinum A exotoxin for the aging neck Dermatol Surg 24 1232–1234 Occurrence Handle1:STN:280:DyaK1M%2FltFyjuw%3D%3D Occurrence Handle9834744
A Carruthers J Carruthers (1998) ArticleTitleClinical indications and injection technique for the cosmetic use of botulinum A exotoxin Dermatol Surg 24 1189–1194 Occurrence Handle1:STN:280:DyaK1M%2FltFyjsQ%3D%3D Occurrence Handle9834738
A Carruthers J Carruthers (2001) ArticleTitleBotulinum toxin type A: History and current cometic use in the upper face Semi Cutan Med Surg 20 71–84 Occurrence Handle1:STN:280:DC%2BD38%2FitlKgtA%3D%3D
S Fagien (1999) ArticleTitleBotox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery Plast Reconstr Surg 103 701–713 Occurrence Handle1:STN:280:DyaK1M7jsVSqtQ%3D%3D Occurrence Handle9950563
JA Fein CR Boardman S Stevenson SM Selbst (1998) ArticleTitleSaline with benzyl alcohol as intradermal anesthesia for intravenous line placement in children Pediatr Emerg Care 14 119–122 Occurrence Handle1:STN:280:DyaK1c3kt1Kqtw%3D%3D Occurrence Handle9583393
JE Frampton SE Easthope (2003) ArticleTitleBotulinum toxin A (Botox Cosmetic): A review of its use in the treatment of glabellar frown lines Am J Clin Dermatol. 4 709–725 Occurrence Handle14507232
HG Gassner DA Sherris (2000) ArticleTitleAddition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: A randomized controlled study Mayo Clin Proc 75 701–704 Occurrence Handle1:CAS:528:DC%2BD3cXls1GmtbY%3D Occurrence Handle10907385
KA McNellis (1998) ArticleTitleIntradermal bacteriostatic 0.9% sodium chloride containing the preservative benzyl alcohol compared with intradermal lidocaine hydrochloride 1% for attenuation of intravenous cannulation pain AANA J 66 583–585 Occurrence Handle10488265
J Niamtu SuffixIII (1999) ArticleTitleAesthetic uses of botulinum toxin A J Oral Maxillofac Surg 57 1228–1233 Occurrence Handle10513870
GA Nuttall MR Barnett RL Smith SuffixII TK Blue KR Clark BW Payton (1993) ArticleTitleEstablishing intravenous access: A study of local anesthetic efficacy Anesth Analg 77 950–953 Occurrence Handle1:STN:280:ByuD38fhtVU%3D Occurrence Handle8214733
WL St Peter MJ Lewis MG Macres (1998) ArticleTitlePain comparison after subcutaneous administration of single-dose formulation versus multidose formulation of epogen in hemodialysis patients Am J Kidney Dis 32 470–474 Occurrence Handle1:STN:280:DyaK1cvhtVyrsg%3D%3D Occurrence Handle9740164
JM Williams NR Howe (1994) ArticleTitleBenzyl alcohol attenuates the pain of lidocaine injections and prolongs anesthesia J Dermatol Surg Oncol 20 730–733 Occurrence Handle1:STN:280:ByqD2M7ps1c%3D Occurrence Handle7962932
VH Yuen PJ Dolman (1999) ArticleTitleComparison of three modified lidocaine solutions for use in eyelid anesthesia Ophthal Plast Reconstr Surg 15 143–147 Occurrence Handle1:STN:280:DyaK1M3gsFKntg%3D%3D Occurrence Handle10189646
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sarifakioglu, N., Sarifakioglu, E. Evaluating Effects of Preservative-Containing Saline Solution on Pain Perception During Botulinum Toxin Type-A Injections at Different Locations: A Prospective, Single-Blinded, Randomized Controlled Trial. Aesth Plast Surg 29, 113–115 (2005). https://doi.org/10.1007/s00266-004-0062-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-004-0062-0